NDC 43598-009-74 - Guaifenesin 600 mg
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43598-009
- Requested NDC
- 43598-009-74
- Package NDCs from labels
- 43598-009-74, 43598-009-25, 43598-009-37
- Manufacturer
- Dr. Reddy's Laboratories Inc.
- Effective date
- 2025-09-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Drug Facts | Dr. Reddy's Laboratories Inc. | 2025-09-22 | HUMAN OTC DRUG LABEL |
| Drug Facts | Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories Limited FTO3 | Quality Packaging Specialists International, LLC | 2024-07-26 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-009-25 | Guaifenesin 1200 mg | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 6 | |
| 43598-009-37 | Guaifenesin 1200 mg | 3 in 1 CARTON | TABLET, EXTENDED RELEASE | 3 | 6 | |
| 43598-009-74 | Guaifenesin 1200 mg | 14 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 14 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43598-009 | GUAIFENESIN 600 MG (GUAIFENESIN ) TABLET, EXTENDED RELEASE GUAIFENESIN 1200 MG (GUAIFENESIN) TABLET, EXTENDED RELEASE [DR. REDDY'S LABORATORIES INC.] | 6 | Current NDC, Legacy NDC, 3 package rows | 20240727_99307c61-5df3-0a83-1e21-ddb03bc905b4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Altituss | DEXTROMETHORPHAN HBR, GUAIFENESIN | Alternative Pharmacal Corporation | e4ac96f5-2a3a-42a8-8db5-80de4dcdbd44 | 2025-12-30 | Warnings | 495W7451VQ |
| Biocof | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HCL | Advanced Generic Corporation | 6ae6a0cb-b4fc-4e7d-aefc-6a52ca1ae3d6 | 2025-12-30 | Warnings | 495W7451VQ |
| Altipres Pediatric | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Advanced Generic Corporation | 2a336896-a2f8-2a0c-e063-6294a90ae03a | 2025-12-30 | Warnings | 495W7451VQ |
| Altipres | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Alternative Pharmacal Corporation | c5a43107-3eb8-46bb-87bd-20deafe28c3f | 2025-12-30 | Warnings | 495W7451VQ |
| ONETOOTHCLINIC TOOTH | SILICON DIOXIDE, TOCOPHEROL ACETATE, SODIUM PYROPHOSPHATE | CONE MEDICAL Co., Ltd. | 9a567c9e-b8ce-7bf1-e053-2995a90aff2b | 2025-12-30 | Warnings | ETJ7Z6XBU4 |
| ONETOOTH CLINIC TOOTH | SILICON DIOXIDE, TOCOPHEROL ACETATE, TETRASODIUM PYROPHOSPHATE | CONE MEDICAL Co., Ltd. | bd50abcd-8a85-2923-e053-2995a90a109b | 2025-12-30 | Warnings | ETJ7Z6XBU4 |
| Tusnel EX | GUAIFENESIN | Llorens Pharmaceutical International Division, Inc. | 77c16288-68c4-476c-995f-86f505663270 | 2025-12-29 | Warnings | 495W7451VQ |
| Tusnel DM | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Llorens Pharmaceutical International Division, Inc. | fe457e6d-422d-496c-bcb9-33594f3c42ff | 2025-12-29 | Warnings | 495W7451VQ |
| Tusnel Diabetic | DEXTROMETHORPHAN, GUAIFENESIN | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | 66b3c094-809e-4d2c-bc15-46563de685cb | 2025-12-29 | Warnings | 495W7451VQ |
| Sorbutuss NR | SORBUTUSS | Dextrum Laboratories Inc. | 304f1d5a-218c-51ae-e054-00144ff88e88 | 2025-12-26 | Warnings | 495W7451VQ |
| TUSSIN CF | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | AptaPharma Inc. | c005c6cf-7891-463e-b65d-1129ad4bf6ec | 2025-12-26 | Warnings | 495W7451VQ |
| CHILDRENS MUCUS RELIEF COUGH - CHERRY FLAVOR | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | AptaPharma Inc. | 9ae6fe74-80cd-482a-b3b9-3acafd6708ec | 2025-12-26 | Warnings | 495W7451VQ |
| Tussin Expectorant | GUAIFENESIN | AptaPharma, Inc. | ca8fa216-09c1-42b2-a95b-fa3d0f13363c | 2025-12-26 | Warnings | 495W7451VQ |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 3b7e0ee7-4dda-4bbe-842c-6cbbc208acd5 | 2025-12-26 | Warnings | 495W7451VQ |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 0d604fc6-7bb9-4f7c-99cd-fdae4df4bb6f | 2025-12-26 | Warnings | 495W7451VQ |
| Mucus Relief DM | DEXTROMETHORPHAN HBR 20MG GUAIFENESIN 400MG | Pioneer Life Sciences, LLC | 3ce0f096-906e-47eb-8061-0ac1e9d8ea55 | 2025-12-26 | Warnings | 495W7451VQ |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 1194c338-e115-4105-93d8-9ab833c43193 | 2025-12-26 | Warnings | 495W7451VQ |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 9c9e558d-d991-4a2e-aa13-37c0b08071e6 | 2025-12-26 | Warnings | 495W7451VQ |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 1695e7ea-2f83-4d3a-980e-c91be6c1f2a5 | 2025-12-25 | Warnings | 495W7451VQ |
| GUAIFENESIN | GUAIFENESIN | Pharbest Pharmaceuticals, Inc. | 0bf70fb4-d3c8-476d-b864-4eadc697a7d8 | 2025-12-24 | Warnings | 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.